Spine Surgery Technologies, Products Generating Clinical Success, Driving and Sustaining Large Markets, According to a March 2005 Analysis Report by MedMarket Diligence
The worldwide market for products in spine surgery is poised for strong and sustainable growth through the coming decades as a range of new products, from artificial discs to use of minimally invasive techniques and wealth of osteobiologics find their way into a growing medical practice comprised of an active baby boomer population. The worldwide markets for these technologies, and the opportunities emerging, are detailed in a newly published report by MedMarket Diligence.
(PRWEB) March 10, 2005 -- "The spine surgery marketplace is an arena for
robust growth and market development of medical technologies," says Patrick
Driscoll, President of MedMarket Diligence. "Since there is a large patient
pool, numerous therapeutic alternatives possible for ameliorating spine-related
problems and the advent of a very diverse range of technologies from image
guidance, artificial discs, osteobiologics and others, the market will see
sustainable revenue growth for well into the next few decades."
The
MedMarket Diligence report on spine surgery is a worldwide medical market and
technology assessment of the products, technologies, and companies in the market
for spine surgical technologies for the treatment of congenital spine disorders,
inflammatory and infectious diseases of the spine, degenerative spine diseases,
mechancial disorders of the spine (herniation, stenosis, myelopathy, etc.),
spinal trauma and tumors of the spine. Technologies addressed include the range
of traditional "open" surgical procedures (fusion, corpectomy, foraminotomy,
laminectomy, etc.) and minimally invasive procedures
(vertebroplasty/kyphoplasty, microscoopic discectomy, disc decompression,
endoscopic scoliosis surgery, minimally invasive bone grafting, etc.), as well
as the full range of other device and osteobiologic technologies being applied
or developed.
Companies involved in the market or pursuing technologies
include: Aastrom Biosciences, AlloSource, Alphatec Manufacturing, Alphatec
Manufacturing, Altiva Corporation, Arthrocare Corporation, Arthrocare/Parallax
Medical, A-Spine USA,Inc., B. Braun Aesculap, Biocomposites, Biomet/Interpore
Cross, Blackstone Medical, Cambridge Scientific, Cardinal Health, Cell-Based
Bone Graft Substitutes, Cloward Instrument Corporation, Co-Ligne AG, Cook, Corin
Group, Cortek, DePuy Spine, Disc-O-Tech Medical Technologies, Ltd., EBI, L.P.,
Encore Medical Corporation, Endius, Endospine Kinetics Limited, ETEX
Corporation, HydroCision, Integra LifeSciences, Interpore Cross International,
IsoTis OrthoBiologics, Jupiter Surgical Systems, Kyphon Inc., LifeNet, MacroPore
Biosurgery Inc., Medtronic Sofamor Danek, MTF (Musculoskeletal Transplant
Foundation), NeuColl, NuVasive, Orquest, Ortho Development Corporation,
Orthovita, Osiris Therapeutics, OsteoBiologics, Osteoimplant Technology,
Osteotech, Scient’X, SeaSpine, Smith & Nephew, Spinal Concepts, Spine Vision
Inc., Spineology Inc., Stryker Biotech, Stryker Biotech, Stryker Spine,
Synthes-Stratec, Therics, Trimedyne, Tutogen Medical, Valleylab, Verigen,
Vertebron Inc., Wright Medical Technology and others.
Details of the
March 2005 report are available at www.mediligence.com/rpt-m501.htm.
MedMarket Diligence
provides tactical decision-making solutions on medical technology to the medical
products and investment industries. The company publishes the MedMarkets
newsletter, a monthly analysis of the market implications of new medical
technology and dedicated reports on technology markets. For additional details,
contact Patrick Driscoll at email or call 949-859-3401 or toll-free (in the
U.S.). 1-866-820-1357.
# # #
Source : http://www.prweb.com/releases/2005/3/prweb216981.htm